[Translation] A randomized, double-blind, placebo-controlled, dose-escalating phase I clinical study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of AOD113408 injection after single subcutaneous administration in healthy subjects and multiple subcutaneous administration in overweight or obese subjects
主要目的:
评价AOD113408注射液在健康受试者单次和在超重或肥胖受试者中多次皮下注射的安全性和耐受性
次要目的:
(1)评价AOD113408注射液在健康受试者中单次和在超重或肥胖受试者中多次皮下注射的药代动力学特征
(2)评价AOD113408注射液在健康受试者中单次和在超重或肥胖受试者中多次皮下注射的药效动力学特征
(3)评价AOD113408注射液在健康受试者中单次和在超重或肥胖受试者中多次皮下注射的免疫原性
[Translation] Primary objectives:
To evaluate the safety and tolerability of AOD113408 injection after single and multiple subcutaneous injections in healthy subjects
Secondary objectives:
(1) To evaluate the pharmacokinetic characteristics of AOD113408 injection after single and multiple subcutaneous injections in healthy subjects
(2) To evaluate the pharmacodynamic characteristics of AOD113408 injection after single and multiple subcutaneous injections in healthy subjects
(3) To evaluate the immunogenicity of AOD113408 injection after single and multiple subcutaneous injections in healthy subjects